Marketing-authorisation holder · Singapore
Gensci Singapore Pte. Ltd.
1 medicine in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
1 medicine
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE42 mg/ syringe · Injection, suspension, extended release | Leuprorelin | Singapore | Authorised | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 1 | 1 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Endocrine therapyAntineoplastic and immunomodulating agents · ATC L02A
Top substances
The active substances in most of its medicines.